Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

Beats Expectations, Tariff Plan in Place GSK reported Q1 turnover of £7.52 billion and core EPS of 44.9 pence, narrowly ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

The Cervarix market report offers a comprehensive analysis of market size, growth potential, and segmentation, highlighting trends across major regions. Key drivers include rising HPV awareness, ...

The GSK share price took a dive in response to US import tariffs, but the company says it should be able to handle them. The ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...